FKBP14 Protein (AA 20-211) (His tag)

N° du produit ABIN667027

Détail du produit

Antigène: FKBP14 (FK506 Binding Protein 14, 22 KDa (FKBP14))

Type de proteíne: Recombinant

Attributs du protein: AA 20-211

Origine: Humain

Source: Escherichia coli (E. coli)

Purification/Conjugué: Cette FKBP14 protéine est marqué à la His tag.

Application: SDS-PAGE (SDS)

Attributs du produit: FKBP14, 20-211aa, Human, His tag, E.coli

Pureté: > 90 % by SDS - PAGE

Information d'application

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/ml (determined by Bradford assay)

Buffer: Liquid in Phosphate-Buffered Saline (pH 7.4) containing 10% glycerol

Stock: 4 °C

Détail du antigène

Antigène: FKBP14 (FK506 Binding Protein 14, 22 KDa (FKBP14))

Autre désignation: FKBP14 (FKBP14 Produits)

Synonymes: MGC81908 Protein, MGC89927 Protein, BC029109 Protein, FKBP-14 Protein, FKBP22 Protein, EDSKMH Protein, IPBP12 Protein, FK506 binding protein 14 Protein, FK506 binding protein 14 L homeolog Protein, FK506 binding protein 14, 22 kDa Protein, peptidyl-prolyl cis-trans isomerase FKBP14 Protein, FKBP14 Protein, fkbp14.L Protein, fkbp14 Protein, LOC100228355 Protein, Fkbp14 Protein

Sujet: FKBP14, also known as 22 kDa FK506-binding protein, is an enzyme that accelerates the folding of proteins during protein synthesis. This protein contains two EF-hand domains and one PPIase FKBP-type domain. Truncation of the amino-terminus of FKBP14 greatly reduces peptidyl prolyl cis-trans isomerase activity, therefore suggesting that the PPIase FKBP-type domain must be located at the N-terminus. Recombinant human FKBP14 protein, fused to His-tag at N-terminus, was expressed in E.coli and purified by using conventional chromatography. Synonyms: FKBP22, Peptidyl-prolyl cis-trans isomerase FKBP14, 22 kDa FK506 binding protein, FK506 binding protein 14 (22 kDa), FK506 binding protein 14, FKBP 22, FKBP22, Peptidyl prolyl cis trans isomerase, PPIase, Rotamase. NCBI no.: NP_060416

Poids moléculaire: 24.2 kDa (213aa) confirmed by MALDI-TOF

Pathways: ER-Nucleus Signaling